Most nursing home docs don’t prescribe SGLT2Is yet for diabetes: study
By
Alicia Lasek
Apr 23, 2023
Most nursing home clinicians do not include sodium/glucose cotransporter-2 inhibitors (SGLT2Is) in their diabetes treatment toolkit. But use of the glucose-lowering drugs is growing in this setting, investigators...
AHA highlights game-changing benefits of newer diabetes drugs
By
Alicia Lasek
Sep 30, 2020
Newer classes of diabetes drugs reliably protect patients from heart and kidney damage associated with type 2 diabetes and chronic kidney disease, an American Heart Association analysis finds. Increased...
Two groundbreaking diabetes drugs endorsed by EU regulators
By
Alicia Lasek
Feb 02, 2020
A fast-acting version of Liumjev (insulin lispro), and an oral (non-injectable) version of semaglutide have been recommended for approval.
FDA approves new kind of oral diabetes drug
Apr 03, 2013
The Food and Drug Administration recently approved a new kind of type 2 diabetes drug to help better control glucose levels. Invokana is the first diabetes treatment approved in a new class of drugs known...